One-year efficacy and safety of the telehealth system in poorly controlled type 2 diabetic patients receiving insulin therapy.

Source: Chen, S. Y., et al. 2011. - Pubmed ID: 21882998

Setting: Taiwan, General hospital diabetes center.

Study design:

CT-pro

Follow up: 1 year

Patient group:

Sample size:

Total: 64

IG: 32

CG: 32

Inclusion criteria: HbA1c > 7% for 1 year.

Type of technology:

Home monitoring equipment:

– blood glucose

Telehealth data analysis platform

 

Teleconsultation

– Telephone calls

Intervention:

Intervention: Diabetes management program was performed for all patients. Patients assigned to the telehealth system received a 1-hour education program to initiate the use of the telehealth system. Patients received phone calls from caregiver on days 3, 7, 14, and 60 after registration for specific barrier education, data explanation, confidence establishment, and insulin dose adjustment.

Patients had to visit outpatient clinics on day 30 and every 3 months.

Duration: 1 year

Add on: NA

Control group: Usual care

Clinical effect/ Patient safety:

Clinical effect:

Intervention:

– HbA1c ↓

– Bodyweight →

Control:

– HbA1c →

– Bodyweight ↑

Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences:  NA

Staff experiences: NA

Costs and organization:

Investment:

Home monitoring equipment

– Blood glucose

Running:

Staff resources

– staff for monitoring and phonecalls

Organization: NA

Health care utilization:

– Hospitalization any cause ↓

– Hypoglycemic events →

– ER visits →

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)